NeurAxis, Inc. (NRXS) is a publicly traded company in the Healthcare sector, operating within the Biotechnology industry. The company is headquartered in Carmel, IN, United States. The current CEO is Brian Carrico.
NRXS has IPO date of 2023-08-09, 21 full-time employees, listed on the American Stock Excha, a market capitalization of $78.31M.
NeurAxis, Inc. operates as a neuromodulation therapy device company in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome healthcare companies primarily hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.
